From: Prevalence of HBV and HCV infections, Bhutan, 2017: Progress and next steps
Prevalence of HBsAg among 171 children 1-4 years and 375 children 5-17 years with test performed and available | ||||||||
---|---|---|---|---|---|---|---|---|
Weighted average of vaccination coverage | Among vaccinated | Among unvaccinated | ||||||
Vaccinated | Total | (%) | N/Total (%) | 95% confidence interval | N/Total (%) | 95% confidence interval | ||
Children 1–4 yearsa | Birth doseb | 136 | 185 | 70% | 0/127 (0%) | – | 0/44 (0%) | – |
Third dose | 174 | 185 | 92% | 0/164 (0%) | – | 0/7 (0%) | – | |
Three doses, with birth dose | 135 | 185 | 70% | 0/126 (0%) | – | 0/45 (0% | – | |
Children 5–17 yearsc | Birth dosed | 45 | 394 | 16% | 1/40 (2.4%) | 0.4–15.0 | 2/335 (0.4%) | 0.1–1.5 |
Third dose | 253 | 394 | 59% | 3/246 (1.1%) | 0.3–3.9 | 0/129 (0%) | – |